Zdrowie i gospodarka · 28/06/2023

FDA Issues Final Guidance on Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements

The US Food and Drug Administration (FDA) has released a final guidance for industry on how to present quantitative efficacy and risk information in direct-to-consumer promotional labeling and advertisements for prescription and over-the-counter drugs.